Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective — Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD)
Jeffrey Shuren, P. Murali Doraiswamy
Topics & Concepts
DiseaseClinical trialAlzheimer's diseaseNeuroscienceMedicinePerspective (graphical)PsychologyInternal medicineComputer scienceArtificial intelligenceCancer-related cognitive impairment studies